Notable Achievements – July 2019

Congratulations to Dr Kambiz Kalantari who is one of two winners of the 2019 American Society of Nephrology’s (ASN) Mid-Career Distinguished Educator Award. This award honors individuals who have made substantial and meritorious contributions in clinical or research education as it relates to nephrology on both the local and national levels.

Congratulations to UVA and Hematology/Oncology’s Dr Patrick Dillon on receiving a grant from the Department of Defense for Breast Cancer research.

Congratulations to Michelle Otto, ANP, MSN, RN on celebrating her five years of service with UVA Community Oncology.

Congratulations to Dr Pranav Patel on celebrating his five years of service with UVA Community Oncology.

Congratulations to Hematology/Oncology’s Ewa Kubicka on being promoted to Lab Specialist in Dr. Lum’s Labs.

Congratulations to Hematology/Oncology’s Taylor Matousek on her new position as Grant and Contracts Specialist in Dr. Lum’s Labs.

Congratulations to Hematology/Oncology’s Amber Woods on her new position as Research Associate in Dr. Lum’s Labs.

Congratulations to Hematology/Oncology’s Dr Richard Hall on celebrating his 5 years of service with UVA.

Congratulations to Hematology/Oncology’s Dr Elizabeth Gaughan on being promoted , from Assistant Professor of Medicine, to Associate Professor of Medicine, effective July 1, 2019.

Congratulations to Hematology/Oncology’s Dr Hillary Maitland, on being promoted from Assistant Professor of Medicine, to Associate Professor of Medicine, effective July 1, 2019.

Congratulations to Dr Craig Portell, on being promoted from Assistant Professor of Medicine, to Associate Professor of Medicine, effective July 1, 2019.

Press-Ganey recognitions for outstanding patient satisfaction: All physicians were in the 99th percentile score. Dr Michael Douvas was one of only 4 physicians in the Health System at 100%. Congratulations to the following physicians on receiving this award: Drs Christiana Brenin, John Densmore, Michael Douvas, Robert Dreicer, Elizabeth Gaughan, Ryan Gentzler, William Grosh, Richard Hall, Tamila Kindwall-Keller, Craig Portell, Michael E. Williams.

Congratulations to Drs Michael Douvas, Ryan Gentzler, Richard Hall, Craig Portell and Daniel Reed on their recent publication. Treatment of refractory ALK rearranged anaplastic large cell lymphoma with alectinib Clin Lymphoma Myeloma Leuk. (2019), pp. S2152-2650

2019 American Association for Cancer Research (AACR) Annual Meeting Highlights:
Lawrence Lum, MD, DSc assistant professors Archana Thakur, PhD and Manley Huang, PhD and research assistant Johnson Ung recently traveled to Atlanta, GA, for the 2019 American Association for Cancer Research (AACR) annual meeting. They presented three abstracts in three different poster sessions: “Induction of Highly Efficacious Anti-tumor and Immune Modulating Activity: Cell-Free Off-the-Shelf Therapeutic Modality,” “Anti-CD3 x Anti-EGFR Bispecific Antibody Armed T cells (EGFR BATs) Kill Resistant Pancreatic Cancer Cell Lines and Increase Sensitivity to Chemotherapy,” and “Anti-CS1 x Anti-CD3 Bispecific Antibody (BiAb)-Armed Anti-CD3 Activated T Cells (CS1-BATs) Specifically Kill CS1+ Myeloma Cells and Release Type-1 Cytokines.” Two more abstracts were recently accepted by the American Society of Clinical Oncology (ASCO): “Phase II Clinical Trial using Anti-CD3 x Anti-HER2 Bispecific Antibody Armed Activated T Cells (HER2 BATs) for HER2 Negative (0-2+) Metastatic Breast Cancer” and “Exceptional Clinical and Immune Responses Using Anti-CD3 x anti-EGFR Bispecific Antibody Armed T cells (BATs) for Locally Advanced or Metastatic Pancreatic Cancer.”

Filed Under: News and Notes, Notable Achievements

Tags: , , , , , , , , ,